Bacoside A
CAS: 11028-00-5
Ref. TM-T3426
1mg | 181,00 € | ||
5mg | 448,00 € | ||
10mg | 642,00 € | ||
25mg | 1.002,00 € | ||
50mg | 1.382,00 € | ||
100mg | 1.827,00 € |
Produktinformation
- (5R,8R,9S,10S,13R,14R,17S)-3-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5S)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-10-(hydroxymethyl)-4,4,8,14-tetramethyl-1,2,3,5,6,7,9,11,12,13,15,17-dodecahydrocyclopenta[a]phenanthren-16-one
- 3-[(O-α-<span class="text-smallcaps">L</smallcap>-Arabinopyranosyl-β-<smallcap>D</span>-glucopyranosyl)oxy]-19,20-dihydroxydammar-24-en-16-one
- Dammar-24-en-16-one, 3-[(O-α-<span class="text-smallcaps">L</smallcap>-arabinopyranosyl-β-<smallcap>D</span>-glucopyranosyl)oxy]-19,20-dihydroxy-
- Dammar-24-en-16-one, 3-[(α-<span class="text-smallcaps">L</smallcap>-arabinopyranosyl-O-β-<smallcap>D</span>-glucopyranosyl)oxy]-19,20-dihydroxy-
Bacoside A has a possible anticancer activity that could be inducing cell cycle arrest and apoptosis through Notch pathway in GBM in vitro. It exerts cytoprotective efficacy by attenuation of ROS generated through oxidative stress by an increase in the concentration of antioxidant enzymes and sustain membrane integrity which leads to restoring the damage caused by tBHP. Bacoside A can able to inhibit the progression of Experimental Autoimmune Encephalomyelitis (EAE) may be by the inhibition of inflammatory cytokines and chemokine evolved during active EAE. Bacoside A also has vasorelaxation.
Chemische Eigenschaften
Technische Anfrage zu: TM-T3426 Bacoside A
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.